Patent · US Active

S-enantiomerically enriched compositions of beta blockers for treating amyotrophic lateral sclerosis

US11007158B2 · kind B2 · utility

0Cited by

0References

14Claims

0Family size

Assignee

ACTIMED THERAPEUTICS LIMITED · GB

Inventors

Andrew J. S. Coats · Melbourne, AU
Stefan Anker · Berlin, DE
Jochen Springer · Falkensee, DE

Key dates

Filing date	Oct 18, 2019
Grant date	May 18, 2021
Priority date	—
Expiry date	Oct 18, 2039

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P25/28
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to S-enantiomerically enriched compositions of beta blockers and uses thereof, including uses of the beta blocker compositions for treating amyotrophic lateral sclerosis. The beta blocker compositions can also be used for preventing loss of lean mass, preventing body weight loss in subjects, improving quality of life in subjects, and prolonging survival in amyotrophic lateral sclerosis patients. The beta blocker can be oxprenolol or a pharmaceutically acceptable salt thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.